The documentary world just got blindsided. A previously undisclosed film about Elizabeth Holmes, the disgraced Theranos founder, premiered at the Telluride Film Festival over the weekend, catching nearly everyone off guard. Nathan Fielder and Lance Oppenheim collaborated on ‘You Can See Everything,’ a project that managed to stay entirely under the radar until its debut screening—a feat virtually impossible in today’s hyperconnected media landscape.
What makes this particular production noteworthy isn’t just the secrecy surrounding its development. The real story here is what the filmmakers secured: genuine, extended access to Holmes herself. In an era where she’s generally kept out of public view, the chance to hear directly from the Theranos founder about her perspective on the company’s collapse represents a rare media moment. It’s a reminder that the technology news cycle never truly moves on from major scandals; they simply simmer until a new angle emerges.
The Unprecedented Access Challenge
Getting someone to open up about a public downfall of this magnitude is extraordinarily difficult. Holmes has largely maintained her position through legal proceedings and appeals, with her communication carefully controlled. That Fielder and Oppenheim managed to create something with her generous participation suggests either an extraordinary amount of trust was built, or they presented a compelling artistic vision she felt warranted her time. For documentary makers accustomed to subjects who dodge cameras and lawyers, this represents a significant development in how complex, controversial stories get told.
Why This Moment Matters for Industry Trends
The documentary world has evolved considerably since the original ‘The Inventor: Out for Blood in Silicon Valley’ dropped in 2019. That HBO project helped set the cultural narrative around Holmes and Theranos for several years. Now, seven years into the broader story, a new interpretation arriving through a different creative lens suggests that important narratives deserve multiple tellings. The timing coincides with growing scrutiny in tech regarding founder culture, product validation, and accountability—themes that remain painfully relevant as startups continue launching with ambitious claims and limited proof.
Fielder brings comedic sensibility and documentary experience, while Oppenheim specializes in intimate character studies. Together, they represent a different sensibility than previous Holmes-focused media. This product launch—if we can call a festival premiere that—demonstrates how the documentary form continues evolving as a way to examine technology industry failures and the people behind them.
The Broader Context of Startup Accountability
The Theranos saga hasn’t faded from public memory because the underlying issues persist. Founders continue making bold claims about revolutionary technology. Investors continue backing those claims with minimal scrutiny. Medical claims, in particular, remain a minefield where ambition can outpace reality. Holmes’ story serves as a cautionary tale, but only if it keeps getting told and retold from different angles. A documentary featuring her own voice and perspective, however problematic, adds texture to discussions about how companies fail and what accountability actually looks like.
Whether her participation in this film signals anything about her legal situation or future remains unclear. What’s evident is that filmmakers still believe there’s an audience hungry to understand how someone builds, pitches, and eventually loses a company built on technology that didn’t work as promised.
Key takeaway: The secret documentary premiere at Telluride underscores how major tech industry scandals continue generating cultural interest years after initial coverage. When filmmakers gain genuine access to central figures—particularly controversial ones—it reframes the conversation around accountability, founder narratives, and how we collectively process failure in the technology space.
The real question isn’t whether we needed another Elizabeth Holmes documentary, but whether hearing directly from her, presented through Fielder and Oppenheim’s distinct creative lens, actually changes how we understand what happened at Theranos. Have you followed the Theranos story through different mediums, and do you think additional perspectives on it are valuable, or is it time to move entirely past this particular chapter of startup history?
Get Tech Savvy Digest in your inbox
IT news, cybersecurity, and crypto — the signal, not the noise. No spam, unsubscribe anytime.